Arrowhead Pharmaceuticals Inc (FRA:HDP1)
€ 24.66 4.54 (22.56%) Market Cap: 3.08 Bil Enterprise Value: 2.92 Bil PE Ratio: 0 PB Ratio: 17.54 GF Score: 48/100

Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Mar 17, 2022 / 05:00PM GMT
Release Date Price: €39.34 (+5.64%)
Operator

Line is now open for the 2022 annual meeting of stockholders of Arrowhead Pharmaceuticals.

Christopher Anzalone
Arrowhead Pharmaceuticals, Inc. - President & CEO

Morning. Thank you for joining our virtual meeting of stockholders. I am Christopher Anzalone, the President, CEO, and a Director of Arrowhead and will be serving as the Chairman for today's meeting. The polls are open for voting.

(Conference Instructions) With us today are Doug Given, Chairman of the Board; Mike Perry, Lead Director; Will Waddill, Director and Chair of the Audit and Compensation Committees; Marianne De Backer, Director and Chair of the Nominating Committee; Mauro Ferrari, Director; Oye Olukotun, Director; Patrick OBrien, General Counsel and Corporate Secretary. Also present are representatives of Rose, Snyder & Jacobs, our independent registered public accounting firm.

I hereby call this meeting to order. It has been duly called, and a quorum is present. Four proposals to be voted on were set forth in the meeting in the company's proxy statement.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot